Evaluate Efficacy of Respiratory Rehabilitation Personalized Mobile Services for Respiratory Diseases

Asan Medical Center179 enrolled

Overview

This trial is multicenter prospective study to evaluate clinical efficacy of respiratory rehabilitation personalized mobile services for respiratory disease.

Patients with Lung Cancer or COPD who need respiratory rehabilitation were enrolled in this trial. The subjets were randomized to 3 group(A: Fixed respiratory rehabilitation program group, B: Mixed respiratory rehabilitation program group(Fixed respiratory rehabilitation for 6 weeks, and then responsive respiratory rehabilitation for 6 weeks) and C: Control group(Ordinary rehabilitation service of the site)). Patients in Group A\&B were provided with mobile application and wearable O2 saturation machine and mobile application monitors physical activity and provides 1. how to do stretching, weight training with The-ra Band 2. daily and weekly target of exercise 3. alarm algorithms depending on patient's respiratory status(purse rate and O2 saturation)

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

179

Conditions

Respiratory Disease Lung Cancer COPD

Interventions

Fixed respiratory rehabilitationOTHER

There are 6 step-exercise presented in the application and initial target of exercise will be set according to subject condition. After subject completes targeted exercise, next step will be started.

Responsive respiratory rehabilitationOTHER

The application provide responsive exercise program by changing type and numbers of exercise according to subject condition and exercise ability (This will be assessed with monitored O2 saturation, symptom of dyspnea and pulse rate during exercise)

Eligibility

Sex: ALLMin age: 20 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with Lung cancer or COPD * Patients with FEV1\<80% or FVC\<80% in Pulmonary function test * In case of COPD, post-bronchodilator FEV1 or FVC will be used. * Exceptionally Lung Cancer patients with operation, FEV1\>80% or FVC\>80% will be permitted * The distance walked for 6 minutes in 6-minute walk test ≥ 150 m * Patients with android phone * Patients who voluntarily agree to study participation and provide written informed consent form Exclusion Criteria: * Patients with diseases which could be cause of death or significant disability for 1 year after study enrollment. * Patients with diseases that are difficult to walk or improve walking at screening * Patients with significant diseases which are difficult to include in this study in accordance with the investigator's judgment * Patients who are illiterate or have communication limitations * Patients who have a difficulty to complete a questionnaire or are uncooperative due to deterioration of recognition function

Locations (5)

Wonju Severance Christian Hospital

Wŏnju, Gangwon-do, South Korea

Hanyang University Guri Hospital

Guri-si, Gyeonggi-do, South Korea

KyungHee University Medical Center

Seoul, South Korea

Asan Medical Center

Seoul, South Korea

Outcomes

Primary Outcomes

change from baseline in Modified Medical Research Council dyspnea score

The MMRC dyspnea scale is a five-option grading system. The scale measures a person's limitation base on a scale of 0-4 and uses the final value to determine how much disability is caused by shortness of breath.

Time frame: 12 weeks

change from baseline in COPD Assessment Test(CAT) score

The CAT is a validated, short and simple subject completed questionnaire which has been developed for use in routine clinical practice to measure the health status of subjects with COPD. Subjects are scored on eight items (cough, phlegm, chest tightness, breathlessness, activity limitation, confidence, sleep and energy) on a scale of 0-5 depending on their impact. The sum of scores for each item gives the subject's impact score ranging from 0 (no impact) to 40 (worst possible impact).

Time frame: 12 weeks

change from baseline in real distance walked for 6 minutes

Time frame: 12 weeks

Secondary Outcomes

change from baseline in Physical activity

Physical activity will be assessed with the daily walking distance monitored by the application and wearable device.

Time frame: 12 weeks

subject satisfaction with health status

changed from baseline in EQ-5D-5L

Time frame: 12 weeks

subject satisfaction with service

Assessment tool: Patient's Global Assessment - Subjects are scored on four items (general, easy-to-follow, helpful in exercise and Physical fitness ) on a scale of 1-5 depending on their satisfaction level. The sum of scores for each item will be used for assessement of the subject's satisfaction in the trial.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.